Related by context. All words. (Click for frequent words.) 69 RSD# oral 69 Zemplar Capsules 69 dextofisopam 69 Anturol TM 68 bicifadine 68 lomitapide 67 MoxDuo TM IR 67 Proellex TM 67 forodesine 67 Phase 2a trial 67 alvespimycin 67 elotuzumab 67 MAGE A3 ASCI 67 cobiprostone 67 Phenoptin 67 Phase IIIb clinical 67 faropenem 67 Elocalcitol 67 cannabinor 67 Fibrillex TM 67 sitaxsentan 67 Phase 2a clinical trials 67 omecamtiv mecarbil 66 ularitide 66 YONDELIS 66 incyclinide 66 Phase IIb clinical trials 66 INTEGRILIN 66 Phase IIB 66 CIMZIA ™ 66 Androxal TM 66 lesinurad 66 Phase 1a clinical 66 phase IIa clinical 66 Corlux 66 Cleviprex TM clevidipine 66 Prestara 66 TKM ApoB 66 UPLYSO 65 phase IIb trial 65 Bicifadine 65 Targretin capsules 65 ACAPODENE 65 Phase Ib clinical 65 eprotirome 65 Pruvel 65 balsalazide tablet 65 Aloxi injection 65 DDP# 65 aplindore 65 fostamatinib 65 diabetic neuropathic pain 65 Ketotransdel 65 dacetuzumab 65 Viprinex TM 65 JAK inhibitor 65 tezampanel 65 MEND CABG II 65 CIMZIA TM 65 AQ4N 65 tasimelteon 65 Dyloject TM 65 PHX# 65 AEGR 65 thorough QT 65 Virulizin ® 65 MYDICAR 65 Thorough QT 65 REMINYL ® 65 ZOLINZA 65 nalbuphine ER 65 PREOS R 65 oral methylnaltrexone 65 ITAX 65 acyclovir Lauriad R 65 torezolid phosphate 64 PSMA ADC 64 IV APAP 64 PDE4 inhibitor 64 THALOMID 64 alvimopan 64 sargramostim 64 senicapoc 64 Viramidine 64 Traficet EN 64 ARIKACE ™ 64 dose cohort 64 ACTEMRA TM 64 Cimzia TM 64 antiplatelet agent 64 oral rivaroxaban 64 Ophena TM 64 Civacir 64 MYDICAR ® 64 MIST II 64 CIMZIA TM certolizumab pegol 64 teduglutide 64 budesonide foam 64 oral ridaforolimus 64 midstage clinical 64 EndoTAG TM -1 64 pseudobulbar affect PBA 64 Tarceva TM 64 Azedra 64 pradefovir 64 Cellegesic 64 SILENOR TM 64 OHR/AVR# 64 oral prodrug 64 Clonicel 64 Tasimelteon 64 Archexin 64 MEND CABG 64 Evoltra ® 64 Mipomersen 64 MOVIPREP R 64 E2F Decoy 64 initiate Phase 1b 64 Phase Ib II 64 Cipralex ® 64 PEG PAL 64 Phase #b/#a clinical 64 INTEGRILIN R eptifibatide Injection 64 Prosaptide 64 ACOMPLIA R 64 atacicept 64 oxymorphone ER 64 GLP1 agonist 64 opioid induced bowel dysfunction 64 Zenvia ™ 64 Triolex 64 octreotide implant 64 OvaRex ® MAb 64 Neurodex 64 Phase IIb trials 64 ATACAND 64 PREOS 64 Saforis 64 dexanabinol 64 SinuNase ™ 64 R#/MEM # 64 Surfaxin LS 63 indiplon capsules 63 dose escalation phase 63 Phase #b/#a 63 T Pred 63 HuLuc# 63 relapsed MM 63 Toremifene 63 novel oral anticoagulant 63 ozarelix 63 confirmatory clinical 63 phase IIb clinical 63 custirsen 63 Protexia ® 63 synthetic retinoid 63 oral picoplatin 63 Spiegelmer ® 63 Silodosin 63 nucleotide analog 63 Octreolin 63 trospium 63 NEBIDO 63 Pivotal Phase III 63 TOCOSOL Paclitaxel 63 KRN# 63 RLY# 63 EOquin 63 bardoxolone 63 Telintra 63 Somatuline R Depot 63 oral deforolimus 63 Omigard 63 LibiGel ® 63 Icatibant 63 ancrod 63 BLA filing 63 SILENOR 63 Nuvion 63 Sulonex TM 63 successfully commercialize Iluvien 63 vaginally administered lidocaine 63 AERx iDMS 63 OMNARIS Nasal Spray 63 pitavastatin 63 Alvesco R 63 HCV RESPOND 2 63 Phase 2b study 63 cangrelor 63 MoxDuo IR 63 Phase Ib study 63 schizophrenia CIAS 63 Rezular 63 PRECISE trial 63 selective androgen receptor modulator 63 RSD# iv 63 reslizumab 63 BEMA Buprenorphine 63 placebo controlled clinical 63 TASKi3 63 Pimavanserin 63 Increlex ® 63 eltrombopag 63 histamine dihydrochloride 63 FACTIVE tablets 63 INTERCEPT platelets 63 Zerenex 63 CINTREDEKIN BESUDOTOX 63 INCB# [001] 63 diarrhea predominant irritable 63 urocortin 2 63 dextromethorphan quinidine 63 vidofludimus 63 rhIGF-I/rhIGFBP-3 63 PRADAXA 63 PREGNANT Study 63 oral talactoferrin 63 CTAP# Capsules 63 PROMACTA 63 Huntexil 63 opioid bowel dysfunction 63 riociguat 63 Aryplase 63 Amrubicin 63 lumiliximab 63 Elagolix 63 ENTEREG ® 63 ARCALYST ® 63 Tavocept 62 cinacalcet HCl 62 tesmilifene 62 talactoferrin 62 EDARBI 62 Forodesine HCl 62 phase IIb 62 diabetic gastroparesis 62 omiganan 62 teriflunomide 62 POSIDUR TM 62 ALTACE 62 GLP toxicology studies 62 phase IIa 62 elagolix 62 IMC #B 62 Ereska 62 Plicera 62 RSD# 62 ACZ# 62 Q#IR 62 GSK# [002] 62 CCR9 antagonist 62 PI3K/Akt pathway inhibitor 62 visilizumab 62 AGGRASTAT ® 62 CINOD 62 CaPre TM 62 orBec 62 compound INCB# 62 ATL# [001] 62 HCD# [002] 62 class mGluR5 inhibitor 62 tipifarnib 62 CCX# 62 MGd 62 Vernakalant 62 vernakalant hydrochloride 62 Plenaxis TM 62 Panzem R 62 OMNARIS HFA 62 Phase IIa trial 62 Catena ® 62 TBC# 62 Itopride 62 HepeX B 62 enoximone 62 ruxolitinib 62 Phase IIa trials 62 severe hypercholesterolemia 62 rhThrombin 62 ospemifene 62 tolvaptan 62 Hypoactive Sexual Desire Disorder 62 corticosteroid dose 62 AGGRASTAT R 62 Oxypurinol 62 ToGA 62 Stimuvax R 62 Xanafide 62 Reverset 62 tanespimycin 62 RECOTHROM R 62 mertansine 62 Angiox ® 62 Lofexidine 62 IL# PE#QQR 62 ARCOXIA 62 AZOR 62 celgosivir 62 SUPPRELIN R LA 62 Glypromate 62 Firazyr 62 STRIDE PD 62 octreotide acetate 62 fenofibric acid 62 FROVA 62 FOLOTYN ® 62 Phase 2b clinical trials 62 rhMBL 62 ALVESCO HFA 62 dosing cohort 62 valopicitabine 62 UVIDEM 62 LIVALO 62 Ixempra 62 HDL Selective Delipidation 62 BENICAR HCT 62 IIb clinical trial 62 NP2 Enkephalin 62 DCCR 62 Valdoxan 62 EDEMA3 trial 62 hoFH 62 GALNS 62 Pennsaid R 62 treatment naive genotype 62 Urocidin 62 dose escalation Phase 62 Degarelix 62 confirmatory Phase III 62 ONCONASE R 62 bortezomib Velcade 62 PGL# 62 maximally tolerated dose 62 oral mTOR inhibitor 62 Panzem R NCD 62 non nucleoside HCV 62 tramiprosate Alzhemed TM 62 paliperidone ER 62 miconazole Lauriad ® 62 Tamibarotene 62 Zevalin consolidation 62 goserelin 62 velafermin 62 PRIMO CABG 62 ZEGERID Capsules 62 bazedoxifene 62 cancer neuroendocrine tumor 62 Solazed 62 PhosLo 62 darapladib 62 Hectorol R 62 PhG alpha 1 62 INTEGRILIN ® 62 HuMax EGFr 62 tramiprosate ALZHEMED TM 62 certolizumab 62 RITUXAN 62 Urocortin 2 62 Proquin XR 61 PrevOnco 61 investigational therapies 61 ONTAK 61 ABILIFY R 61 budiodarone 61 Phase IIb clinical 61 Oracea TM 61 NGX# 61 vosaroxin 61 inhaled AAT 61 Hyphanox 61 CIP TRAMADOL ER 61 Dabigatran etexilate 61 refractory AML 61 Phase 2b clinical 61 SinuNase 61 BCR ABL inhibitor 61 Gabapentin GR 61 ENRICH trial 61 Xibrom TM 61 ponatinib 61 BioNumerik 61 Amplimexon 61 evaluable subjects 61 SNT MC# 61 alagebrium 61 TACI Ig 61 Androgel R 61 ARB telmisartan 61 Increlex R 61 prucalopride 61 PRX # 61 dosage regimens 61 Allovectin 7 61 Velac 61 ARIKACE 61 Synavive 61 DepoDur TM 61 PRT# 61 PDE# inhibitors 61 regorafenib 61 Stedivaze 61 Benazepril 61 Genz # 61 volociximab 61 VIAject ™ 61 6R BH4 61 beta 1a 61 VA# [002] 61 Vectibix panitumumab 61 torsemide ER 61 interferon gamma 1b 61 ELACYT 61 Phase 2a clinical 61 DU #b 61 catheter occlusion 61 Phase IIa clinical 61 thymalfasin 61 cathepsin K inhibitor 61 oxypurinol 61 huC# DM4 61 Aptivus ® 61 Argatroban 61 salmeterol fluticasone 61 AMEVIVE 61 ulimorelin 61 trastuzumab DM1 T DM1 61 AeroLEF TM 61 Altastaph 61 MAA submission 61 DSMB recommended 61 ISTODAX 61 squalamine 61 TOLAMBA 61 APTIVUS 61 HuMax CD# 61 ALISTA 61 tafamidis 61 Wellbutrin XL R 61 ULORIC 61 Somatuline Depot 61 orally administered inhibitor 61 KRAS mutations occur 61 TELINTRA 61 inhaled formulation 61 Kepivance 61 ORENCIA R 61 apoptosis inducer 61 maximally tolerated 61 canakinumab 61 ATL/TV# 61 candidate XP# 61 relapsed refractory multiple myeloma 61 Angiox R 61 PEG SN# 61 Frova ® 61 ABILIFY ® 61 Aurexis 61 treprostinil 61 tolevamer 61 Phase III HEAT 61 rufinamide 61 proteasome inhibitor 61 REBETOL combination therapy 61 intranasal formulation 61 enzastaurin 61 trastuzumab DM1 61 Triapine R 61 Tyrima 61 piperacillin tazobactam 61 CHAMPION PCI 61 TNF inhibitor therapy 61 BeneFIX 61 BEMA TM Fentanyl 61 oral FTY# 61 novel VDA molecule 61 deforolimus 61 Cloretazine 61 eniluracil 61 silodosin 61 KIACTA ™ 61 PF # [002] 61 Anturol ® 61 terlipressin 61 Bezielle 61 telaprevir dosing 61 im peramivir 61 TRISENOX ® 61 G#DT 61 MoxDuo 61 Velcade bortezomib 61 herpetic keratitis 61 rasagiline tablets 61 peak plasma concentrations 61 clinical pharmacology studies 61 Tekamlo 61 SomatoKine 61 LEUKINE 61 Phase 2b trial 61 Urocidin TM 61 ridaforolimus 61 EVIZON 61 Dose escalation 61 RhuDex ® 61 ACAPODENE TM 61 Diamyd R 61 Ozarelix 61 trastuzumab emtansine T DM1 61 Somatuline R Autogel R 61 serum phosphate levels 61 GAP #B# 61 benign prostatic hypertrophy BPH 61 sorafenib tablets 61 Certican 61 tasocitinib 61 Flutiform TM 61 tiapamil 61 Tocosol Paclitaxel 61 ONCONASE 61 APRISO 61 milnacipran 61 Cetrorelix 61 Anavex #-# 61 BRINAVESS 61 TYGACIL 61 triglyceride lowering 61 systemic immunosuppressive drugs 61 cariprazine 61 pain palliation 61 ESTRASORB 61 XP# XP# 61 Lubiprostone 61 candidate Zenvia 61 octreotide LAR 61 ThermoDox R 61 Cloretazine ® 61 TNF antagonist 61 Aflibercept 61 Poly ICLC 61 IPLEX 61 alicaforsen enema 61 tecarfarin 61 AGILECT R 61 clevidipine 61 briakinumab 61 NUVIGIL 61 Phase #b/#a trial 61 Ramoplanin 61 efficacy endpoint 60 RHUCIN 60 Apoptone 60 BLA submission 60 MERLIN TIMI 60 Symadex 60 rindopepimut 60 CLIRS trial 60 PEG INTRON 60 Phase Ia 60 PRECISE Trial 60 CIMZIA R 60 cystinosis patients 60 HGS ETR2 60 IoGen 60 CytoFabTM 60 Hsp# Inhibitor 60 sunitinib malate 60 ACEIs 60 CB2 selective receptor agonist 60 TOCOSOL Camptothecin 60 Urokinase 60 EVIZON TM squalamine lactate 60 mGluR5 NAM 60 Loramyc R 60 PROCHYMAL 60 Cethromycin 60 xanthine oxidase inhibitor 60 Alzhemed TM 60 prGCD 60 hepatic encephalopathy 60 RAPAFLO 60 MVax 60 phase Ib clinical 60 evaluating tivozanib 60 SUTENT ® 60 SPRYCEL ® 60 ATryn R 60 CAPHOSOL 60 Relivar 60 CRMD# 60 ENTOCORT EC 60 Phase IIA 60 Orazol 60 recurrent glioblastoma multiforme 60 paliperidone palmitate 60 APTIVUS r 60 AKT inhibitor 60 TREDAPTIVE 60 LEVADEX 60 ZYFLO 60 Golimumab 60 Fortical R 60 evaluating Actimmune 60 selective modulator 60 casopitant 60 Fibrin Pad 60 PXD# 60 Genasense ® oblimersen 60 HuMax CD4 60 SinuNase TM 60 ocrelizumab 60 BEXXAR 60 HZT 60 TASKi2 60 metaglidasen 60 Raptiva ® 60 Troxatyl 60 ZADAXIN ® 60 anticancer compound 60 sorafenib Nexavar 60 CEQ# 60 pafuramidine 60 refractory CLL 60 oral salmon calcitonin 60 LUMINATE 60 Phase IIa clinical trials 60 RAPTIVA 60 rALLy trial 60 PANVAC VF 60 ABSORB trial 60 Factor VIIa 60 galiximab 60 APEX AMI trial 60 Cinryze TM 60 Virulizin R 60 immunotherapeutic vaccine 60 icatibant 60 Pyridorin 60 GAMMAGARD 60 Viprinex 60 apricitabine ATC 60 Xcytrin R 60 tezampanel NGX# 60 rEV# 60 Phenserine 60 CAMPATH 60 Tesmilifene 60 HGS# 60 BROVANA 60 Aerovant 60 TRX1 60 tapentadol ER 60 CBLC# 60 SPRIX ® 60 Alinia 60 ATryn ® 60 Capesaris 60 Novolimus 60 Testim R 60 BRIM2 60 Ostarine 60 telaprevir VX 60 talabostat 60 SEBIVO 60 Study #CL# 60 preclinical toxicology 60 desvenlafaxine succinate 60 Sanctura XR 60 PNP inhibitor 60 oral PTH 60 oxycodone CR 60 IIa trials 60 Zingo TM 60 Nasulin 60 tipranavir r 60 OvaRex R 60 taribavirin 60 Otelixizumab 60 post herpetic neuralgia PHN 60 balsalazide 60 CYCLOSET 60 EGS# 60 Diabetic Macular Edema 60 antiarrhythmic 60 Brinavess 60 gepirone ER 60 Prodarsan ® 60 Atrasentan 60 refractory gout 60 deferiprone 60 #mg dose [002] 60 PEGPH# 60 Cloretazine R VNP#M 60 rALLy clinical trial 60 Rebif ® 60 LEP ETU 60 Genasense ® 60 Arcalyst 60 dalbavancin 60 SYMMETRY trial 60 GSK# [001] 60 brivaracetam 60 Wellbutrin XL ® 60 AMRIX 60 hyperphenylalaninemia HPA due 60 E1 INT TM 60 EOquin TM 60 azelastine 60 Asentar 60 esophageal candidiasis 60 ApoB SNALP 60 adjuvant GIST 60 capsule formulation 60 CYT# potent vascular disrupting 60 PSN# [002] 60 Cinryze ™ 60 Fentanyl TAIFUN R 60 alkylating agent 60 DXL# 60 BIOCEUTICALS 60 Empatic 60 CIPN 60 Phase 1b clinical 60 methylnaltrexone bromide 60 mTOR inhibition 60 cicletanine 60 INCB# [003] 60 AMPAKINE CX# 60 Specifid 60 noninfectious uveitis 60 Thalomid ® 60 Fx #A 60 BrachySil TM 60 TEMODAL 60 IGXT IntelGenx today 60 tubulin inhibitor 60 registrational 60 thetreatment 60 PRESEPT study 60 StemEx 60 Removab 60 Jevtana 60 GRN# 60 dose escalation clinical 60 Neuradiab 60 subcutaneously administered 60 receptor tyrosine kinase inhibitor 60 granulated mesalamine 60 AVINZA 60 omacetaxine mepesuccinate 60 MAXY alpha 60 eosinophilic asthma 60 Emezine 60 ibandronate 60 OraTest R 60 evaluating mipomersen 60 apremilast 60 prokinetic agent 60 Solulin 60 Amoxicillin PULSYS Phase III 60 pivotal bioequivalence 60 glucokinase activator 60 BEMA Granisetron 60 pexelizumab 60 FOR FURTHER INFORMATION ABOUT 60 Pemetrexed 60 HCV SPRINT 60 VITAL Trial 60 ASONEP 60 Cariprazine 60 multicenter Phase II 60 Amoxicillin PULSYS 60 omega interferon 60 PLK1 SNALP 60 Androxal ® 60 neurogenic orthostatic hypotension 60 liposomal formulation 60 acetonide FA 60 aflibercept 60 PFO migraine 60 secondary hyperparathyroidism 60 Voraxaze 60 XmAb# 60 forodesine hydrochloride 60 Perforomist ™ Inhalation Solution 60 STELARA ™ 60 EMSAM 60 randomized Phase IIb 60 chronic idiopathic thrombocytopenic purpura 60 compound AEOL # 60 Phase 1b trial 60 inhaled treprostinil 60 AIM HIGH 60 LEVADEX ™ 60 IMA# 60 Exelixis compounds 60 lanthanum carbonate 60 Dalbavancin 60 Entereg R 60 oral renin inhibitor 60 micafungin 60 Rhucin R 60 sodium Injection 60 lapatinib Tykerb 60 phase IIb study 60 naproxen esomeprazole magnesium 60 LymphoStat B belimumab 60 NEUVENGE 60 REPLAGAL 60 phase 2a 60 PRIMO CABG2 60 Serdolect ® 60 Ventavis 60 Raptiva R 60 Betaferon R 60 IV Busulfex 60 APEX PD 60 KNS # 60 ganetespib 60 complete cytogenetic response 60 Dacogen decitabine 60 albiglutide 60 GnRH antagonist 59 Technosphere Insulin 59 GATTEX ™ 59 Dacogen injection 59 Diamyd ® 59 methylnaltrexone 59 EVIZON TM 59 Celmed 59 Testosterone MDTS ® 59 EMEND 59 bosutinib 59 Mesafem 59 INSPIRE Trial Phase III 59 Exelixis XL# 59 dirucotide MBP# 59 Xenazine ® 59 Phase III Pivotal 59 intravenous dosing 59 LymphoStat B TM 59 Abbokinase 59 Protexia R 59 antithrombotic 59 Dasatinib 59 refractory APL 59 optimal dosing regimens 59 trodusquemine 59 ThGRF 59 olmesartan medoxomil hydrochlorothiazide 59 PrevOnco ™ 59 aurora kinase 59 carcinoid syndrome 59 Insegia 59 Kyowa Kirin 59 RAPTIVA R 59 refractory angina 59 novel histone deacetylase 59 BrachySil ™ 59 Allovectin 7 R 59 JAK inhibitors 59 davalintide 59 TYZEKA 59 serum uric acid sUA 59 immune modulatory 59 pharmacodynamic PD 59 CINQUIL 59 IMPACT DCM clinical 59 venlafaxine ER 59 Increlex TM 59 INVEGA SUSTENNA 59 hypoparathyroidism 59 AGILECT ® 59 Neulasta ® 59 posaconazole 59 BAY #-# 59 Zoledronic acid 59 AZILECT ® 59 OncoGel 59 antiarrhythmic drug 59 Restanza TM 59 Circadin 59 Vimpat R 59 NeuVax 59 Lisofylline LSF 59 MNTX 59 P#X# antagonist 59 CDP# 59 Pharmos pipeline 59 investigational humanized monoclonal antibody 59 FOSRENOL ® 59 non nucleoside inhibitor 59 drug ISA# 59 castrate resistant prostate cancer 59 5 HT2C receptor 59 formerly LymphoStat B 59 Adentri 59 VAPRISOL 59 oxcarbazepine 59 Ketotransdel TM 59 Phase 2a IBS 59 MYCAMINE 59 PRTX 59 NATRECOR R 59 EVIZON ™ 59 subcutaneous PRO 59 Azilect ® 59 ENMD # 59 plasma kallikrein inhibitor 59 initiated Phase Ib 59 Ascend Therapeutics 59 MACUGEN 59 SUPPRELIN LA 59 Actimmune R 59 serum urate 59 ICA # 59 IMiDs 59 anidulafungin 59 Darusentan 59 Avanafil 59 HspE7 59 fund BioSante LibiGel 59 Dapagliflozin 59 C1 INH 59 NUEDEXTA 59 Onco TCS 59 Tykerb lapatinib 59 Preclinical studies suggest 59 Nascobal 59 Gattex 59 LUNESTA TM 59 AERx ® 59 dosing cohorts 59 Zensana TM 59 USL# 59 relapsed MCL 59 CAELYX 59 KAPIDEX 59 RNAi therapeutic targeting PCSK9 59 Thelin TM 59 MOZOBIL 59 PA# [002] 59 initiate multicenter 59 Azedra TM 59 Lixivaptan 59 LIALDA 59 adipiplon 59 Vascugel 59 liprotamase 59 bazedoxifene conjugated estrogens 59 blinded randomized placebo controlled 59 TREANDA 59 Zoraxel 59 myeloproliferative diseases 59 SYCREST 59 Empatic ™ 59 Solzira 59 tenofovir emtricitabine 59 lorvotuzumab mertansine 59 LibiGel Phase III 59 Gaboxadol 59 WILEX 59 Phase III Clinical Trial 59 Ocrelizumab 59 investigational antiplatelet agent 59 adult chronic ITP 59 Menerba 59 DAVANAT 59 XL# SAR# 59 heterozygous FH 59 pegylated interferon alpha 59 subcutaneous formulation 59 rhC1INH 59 Ticagrelor 59 ANCHOR trial 59 EFAPROXYN 59 phase Ib 59 Shigamabs ® 59 cardiac repolarization 59 anagrelide 59 SUTENT 59 INVEGA ® 59 EP #R 59 CD3 monoclonal antibody 59 zileuton 59 angiographic outcomes 59 CR# vcMMAE 59 midstage trials 59 Actimmune ® 59 ELND# 59 acyclovir Lauriad ® 59 Ophena 59 metoprolol succinate 59 Bioral Amphotericin B 59 Linjeta TM 59 ADAGIO study 59 GLPG# 59 targeted radiotherapeutic 59 HQK 59 refractory prostate cancer 59 rilonacept